ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals Inc (RIGL)

38,72
0,43
(1,12%)
Geschlossen 05 Juli 10:00PM
38,75
0,03
(0,08%)
Nach Börsenschluss: 12:16AM

Rigel Pharmaceuticals Inc (RIGL) Insidergeschäfte

-
Filtern nach:
Datum Name des Inhabers Gehandelte Aktien Wertspanne ($) Transaktionstyp Preisspanne ($) Aktien am Meldungsende % Veränderung
2026-06-22Ms. Kamil Ali JacksonIndependent Director-2,50k87,50kAutomatic Disposition35,0010,13k-19,80%
2026-06-01Mr. Dean L. SchornoExec. VP & CFO-928,0015,92kDerivative Exercise and Sale12,70 - 29,8638,19k-
2026-06-01Mr. Dean L. SchornoExec. VP & CFO2,45k38,35kDerivative Exercise and Retained Stock12,70 - 18,7038,19k6,86%
2026-06-01Mr. David A. SantosExec. VP & Chief Commercial Officer-874,0026,10kSale to Issuer29,8622,07k-3,81%
2026-06-01Mr. Raul R. RodriguezPresident, CEO & Director-2,42k72,38kSale to Issuer29,86181,14k-1,32%
2026-06-01Dr. Lisa RojkjaerInsider-850,0025,38kSale to Issuer29,863,54k-19,37%
2026-06-01Mr. Raymond J. FureyExec. VP, CCO, General Counsel & Corporate Secretary-877,0026,19kSale to Issuer29,8612,95k-6,34%
2026-05-26Ms. Kamil Ali JacksonIndependent Director-2,50k72,93kAutomatic Disposition29,1712,63k-16,53%
2026-02-20Dr. Walter H. MoosIndependent Director-4,00k49,44kDerivative Exercise and Sale24,00 - 36,3610,22k-
2026-02-10Dr. Lisa RojkjaerInsider-3,76k130,10kSale to Issuer34,622,81k-57,18%
2026-02-10Mr. Raul R. RodriguezPresident, CEO & Director-7,61k263,35kSale to Issuer34,62179,07k-4,07%
2026-02-10Mr. David A. SantosExec. VP & Chief Commercial Officer-3,55k122,76kSale to Issuer34,6221,33k-14,26%
2026-02-10Mr. Dean L. SchornoExec. VP & CFO-3,55k122,76kSale to Issuer34,6234,02k-9,44%
2026-02-10Mr. Raymond J. FureyExec. VP, CCO, General Counsel & Corporate Secretary-3,55k122,76kSale to Issuer34,6212,21k-22,51%
2026-02-02Mr. David A. SantosExec. VP & Chief Commercial Officer-5,72k205,91kSale to Issuer36,0118,30k-23,81%
2026-01-26Mr. Raul R. RodriguezPresident, CEO & Director40,00k1,10MDerivative Exercise and Retained Stock27,40172,58k30,17%
2026-01-26Mr. Raul R. RodriguezPresident, CEO & Director-40,00k379,47kDerivative Exercise and Sale27,40 - 37,00172,58k-
2026-01-26Mr. Raul R. RodriguezPresident, CEO & Director-44,75k1,65MSale to Issuer36,01 - 37,00172,58k-20,59%
2026-02-02Mr. Raymond J. FureyExec. VP, CCO, General Counsel & Corporate Secretary-3,97k142,89kSale to Issuer36,019,18k-30,18%
2026-02-02Mr. Dean L. SchornoExec. VP & CFO-5,49k197,62kSale to Issuer36,0130,99k-15,05%
2025-12-22Mr. Dean L. SchornoExec. VP & CFO6,50k139,79kDerivative Exercise and Retained Stock18,70 - 24,2026,19k33,02%